BOEHRINGER MARKUS has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MEDICINE AND BIOENGINEERING IN, GALAPAGOS SAS and PULMAGEN THERAPEUTICS ASTHMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ricklin Fabienne | 11 |
#2 | Boehringer Markus | 11 |
#3 | Panday Narendra | 6 |
#4 | Haap Wolfgang | 6 |
#5 | Kuhn Bernd | 5 |
#6 | Hunziker Daniel | 5 |
#7 | Loeffler Bernd Michael | 4 |
#8 | Schmitz Petra | 3 |
#9 | Hilpert Hans | 3 |
#10 | Groebke Zbinden Katrin | 3 |
Publication | Filing date | Title |
---|---|---|
WO2006048152A2 | Dicarboxamide derivatives and their use as factor xa inhibitors |